EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sonic Healthcare's enterprise value is A$16,029 Mil.
Sonic Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$1,546 Mil. Therefore, Sonic Healthcare's EV-to-EBITDA for today is 10.37.
The historical rank and industry rank for Sonic Healthcare's EV-to-EBITDA or its related term are showing as below:
ASX:SHL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.81 Med: 13 Max: 15.85
Current: 10.37
During the past 13 years, the highest EV-to-EBITDA of Sonic Healthcare was 15.85. The lowest was 5.81. And the median was 13.00.
ASX:SHL's EV-to-EBITDA is ranked better than 67.23% of 119
companies
in the Medical Diagnostics & Research industry
Industry Median: 16.29
vs ASX:SHL: 10.37
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Sonic Healthcare EV-to-EBITDA Historical Data
The historical data trend for Sonic Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sonic Healthcare's EV-to-EBITDA
For the Diagnostics & Research subindustry, Sonic Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonic Healthcare's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sonic Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sonic Healthcare's EV-to-EBITDA falls into.
Sonic Healthcare's current Enterprise Value is A$16,029 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sonic Healthcare's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was A$1,546 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sonic Healthcare (ASX:SHL) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Sonic Healthcare's PE Ratio for today is calculated as:
Sonic Healthcare's share price for today is A$26.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sonic Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$1.067.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Sonic Healthcare's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the U.K., the second largest in Belgium and New Zealand and the third largest in the U.S. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the U.S. and 35% in Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:SHL has been successfully added to your 